Pediatric covid-19 vaccines
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75D30123D16649
- Awardee
-
Novavax Inc. UEI ZXHWXURNS6W8
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- 75D30123R72711 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $116,000,000.00
- Maximum order
- $116,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Novavax Inc., a biotechnology company that develops and produces recombinant protein nanoparticle vaccines. The $116 million contract is to provide pediatric COVID-19 vaccines if regulatory approval is obtained.
The IDC is a multiple award vehicle, meaning there are multiple contractors that can compete for individual task orders. The period of performance runs through June 6, 2024. Novavax has previously supported COVID-19 vaccine research, development, and manufacturing efforts through federal contracts, including a $45.7 million definitive contract with the Department of the Army. The IDC scope aims to procure pediatric COVID-19 vaccines to support the CDC's public health mission. Novavax also holds other federal IDV contracts and a Federal Supply Schedule contract with the Department of Veterans Affairs.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$14,861,485 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $19,401,435 | |
| Original award | $7,250 |
Quick answers
Who was awarded contract 75D30123D16649?
75D30123D16649 was awarded to Novavax Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on June 14, 2023.
How much is contract 75D30123D16649 worth?
75D30123D16649's own ceiling is $116,000,000. A single order can be worth up to $116,000,000.
Who can order from contract 75D30123D16649?
75D30123D16649 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75D30123D16649 competed?
The extent of competition for 75D30123D16649 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV